Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.

Purzner T, Purzner J, Buckstaff T, Cozza G, Gholamin S, Rusert JM, Hartl TA, Sanders J, Conley N, Ge X, Langan M, Ramaswamy V, Ellis L, Litzenburger U, Bolin S, Theruvath J, Nitta R, Qi L, Li XN, Li G, Taylor MD, Wechsler-Reya RJ, Pinna LA, Cho YJ, Fuller MT, Elias JE, Scott MP.

Sci Signal. 2018 Sep 11;11(547). pii: eaau5147. doi: 10.1126/scisignal.aau5147.

PMID:
30206138
2.

Patient-derived osteosarcoma cells are resistant to methotrexate.

Dos Santos Cavalcanti A, Meohas W, Ribeiro GO, de Sá Lopes AC, Gholamin S, Razavi M, Hanae Kasai Brunswick T, Avan A, Matheus Guimarães JA, Leite Duarte ME, Kahn SA.

PLoS One. 2017 Sep 21;12(9):e0184891. doi: 10.1371/journal.pone.0184891. eCollection 2017.

3.

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.

Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, Storm TA, Schubert S, Hutter G, Narayanan C, Chu P, Raabe EH, Harsh G 4th, Taylor MD, Monje M, Cho YJ, Majeti R, Volkmer JP, Fisher PG, Grant G, Steinberg GK, Vogel H, Edwards M, Weissman IL, Cheshier SH.

Sci Transl Med. 2017 Mar 15;9(381). pii: eaaf2968. doi: 10.1126/scitranslmed.aaf2968.

PMID:
28298418
4.

Gpr124 is essential for blood-brain barrier integrity in central nervous system disease.

Chang J, Mancuso MR, Maier C, Liang X, Yuki K, Yang L, Kwong JW, Wang J, Rao V, Vallon M, Kosinski C, Zhang JJ, Mah AT, Xu L, Li L, Gholamin S, Reyes TF, Li R, Kuhnert F, Han X, Yuan J, Chiou SH, Brettman AD, Daly L, Corney DC, Cheshier SH, Shortliffe LD, Wu X, Snyder M, Chan P, Giffard RG, Chang HY, Andreasson K, Kuo CJ.

Nat Med. 2017 Apr;23(4):450-460. doi: 10.1038/nm.4309. Epub 2017 Mar 13.

5.

GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma.

Gholamin S, Mirzaei H, Razavi SM, Hassanian SM, Saadatpour L, Masoudifar A, ShahidSales S, Avan A.

J Cell Physiol. 2018 Feb;233(2):866-879. doi: 10.1002/jcp.25793. Epub 2017 May 23. Review.

PMID:
28145567
6.

The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway.

Assad Kahn S, Costa SL, Gholamin S, Nitta RT, Dubois LG, Fève M, Zeniou M, Coelho PL, El-Habr E, Cadusseau J, Varlet P, Mitra SS, Devaux B, Kilhoffer MC, Cheshier SH, Moura-Neto V, Haiech J, Junier MP, Chneiweiss H.

EMBO Mol Med. 2016 May 2;8(5):511-26. doi: 10.15252/emmm.201505421. Print 2016 May.

7.

Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.

Zhang M, Hutter G, Kahn SA, Azad TD, Gholamin S, Xu CY, Liu J, Achrol AS, Richard C, Sommerkamp P, Schoen MK, McCracken MN, Majeti R, Weissman I, Mitra SS, Cheshier SH.

PLoS One. 2016 Apr 19;11(4):e0153550. doi: 10.1371/journal.pone.0153550. eCollection 2016.

8.

Immune Evasion Strategies of Glioblastoma.

Razavi SM, Lee KE, Jin BE, Aujla PS, Gholamin S, Li G.

Front Surg. 2016 Mar 2;3:11. doi: 10.3389/fsurg.2016.00011. eCollection 2016. Review.

9.

Evaluating serum prolactin and serum dehydroepiandrosterone sulfate levels in patients with pemphigus.

Yousefi M, Mozafari N, Hosseini MS, Gholamin S, Razavi SM, Namazi MR, Younespour S.

Int J Dermatol. 2016 Jun;55(6):e332-7. doi: 10.1111/ijd.13199. Epub 2016 Feb 22.

PMID:
26910580
10.

Role of SFRP1 in NPC Metastasis-Letter.

ShahidSales S, Hassanian SM, Mahdavian Zadeh R, Ghayour-Mobarhan M, Gholamin S, Ferns GA, Avan A.

Cancer Prev Res (Phila). 2016 May;9(5):415. doi: 10.1158/1940-6207.CAPR-15-0364. Epub 2016 Feb 15. No abstract available.

11.

MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.

Mirzaei H, Gholamin S, Shahidsales S, Sahebkar A, Jaafari MR, Mirzaei HR, Hassanian SM, Avan A.

Eur J Cancer. 2016 Jan;53:25-32. doi: 10.1016/j.ejca.2015.10.009. Epub 2015 Dec 13. Review.

PMID:
26693896
12.

The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment.

Gholamin S, Pasdar A, Khorrami MS, Mirzaei H, Mirzaei HR, Salehi R, Ferns GA, Ghayour-Mobarhan M, Avan A.

Curr Pharm Des. 2016;22(3):397-403. Review.

PMID:
26561061
13.

Neural Placode Tissue Derived From Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor Cells.

Mitra SS, Feroze AH, Gholamin S, Richard C, Esparza R, Zhang M, Azad TD, Alrfaei B, Kahn SA, Hutter G, Guzman R, Creasey GH, Plant GW, Weissman IL, Edwards MS, Cheshier S.

Neurosurgery. 2015 Nov;77(5):794-802; discussion 802. doi: 10.1227/NEU.0000000000000918.

PMID:
26225855
14.

Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer: The question is still open.

ShahidSales S, Mobarhan MG, Ghasemi F, Gholamin S, Avan A.

Cancer. 2015 Nov 1;121(21):3922-3. doi: 10.1002/cncr.29598. Epub 2015 Jul 28. No abstract available.

15.

γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.

Bui TT, Nitta RT, Kahn SA, Razavi SM, Agarwal M, Aujla P, Gholamin S, Recht L, Li G.

BMC Cancer. 2015 Apr 7;15:225. doi: 10.1186/s12885-015-1232-y.

16.

Biomarker Analysis in CLEOPATRA: Searching for a Sensitive Prognostic Factor in Breast Cancer.

Avan A, Avan A, Maftouh M, Ghayour Mobarhan M, Shahidsales S, Gholamin S.

J Clin Oncol. 2015 May 20;33(15):1711-2. doi: 10.1200/JCO.2014.60.4702. Epub 2015 Apr 13. No abstract available.

PMID:
25870088
17.

Pharmacogenomic modeling in pancreatic cancer—letter.

Avan A, Avan A, Maftouh M, Mobarhan MG, Gholamin S.

Clin Cancer Res. 2015 Mar 15;21(6):1497. doi: 10.1158/1078-0432.CCR-14-2951. No abstract available.

18.

Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: rationale and progress.

Gholamin S, Fiuji H, Maftouh M, Mirhafez R, Shandiz FH, Avan A.

Curr Drug Targets. 2014;15(14):1302-11. Review.

PMID:
25382190
19.

Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.

Nitta RT, Gholamin S, Feroze AH, Agarwal M, Cheshier SH, Mitra SS, Li G.

Oncogene. 2015 Jul;34(28):3688-99. doi: 10.1038/onc.2014.299. Epub 2014 Sep 22.

20.

Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition.

Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, Balansay B, Yu F, Oh S, Woo P, Chen S, Ponnuswami A, Monje M, Atwood SX, Whitson RJ, Mitra S, Cheshier SH, Qi J, Beroukhim R, Tang JY, Wechsler-Reya R, Oro AE, Link BA, Bradner JE, Cho YJ.

Nat Med. 2014 Jul;20(7):732-40. doi: 10.1038/nm.3613. Epub 2014 Jun 29.

21.

Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.

Gholamin S, Razavi SM, Taghavi-Garmestani SM, Ghorbanihaghjo A, Rashtchizadeh N, Safa J, Vatankhah AM, Azizi T, Argani H.

Iran J Kidney Dis. 2014 May;8(3):201-6.

22.

BET bromodomain inhibition of MYC-amplified medulloblastoma.

Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, Cheshier SH, Qi J, Liu KW, Wechsler-Reya R, Weiss WA, Swartling FJ, Kieran MW, Bradner JE, Beroukhim R, Cho YJ.

Clin Cancer Res. 2014 Feb 15;20(4):912-25. doi: 10.1158/1078-0432.CCR-13-2281. Epub 2013 Dec 2.

23.

Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia.

Razavi SM, Gholamin S, Eskandari A, Mohsenian N, Ghorbanihaghjo A, Delazar A, Rashtchizadeh N, Keshtkar-Jahromi M, Argani H.

J Med Food. 2013 Mar;16(3):255-8. doi: 10.1089/jmf.2012.2408. Epub 2013 Feb 25.

PMID:
23437789
24.

Medical versus medical and surgical treatment for brucella endocarditis.

Keshtkar-Jahromi M, Razavi SM, Gholamin S, Keshtkar-Jahromi M, Hossain M, Sajadi MM.

Ann Thorac Surg. 2012 Dec;94(6):2141-6. doi: 10.1016/j.athoracsur.2012.07.006. Epub 2012 Oct 26. Review.

25.

Comparing Peripheral Blood Mononuclear Cell DNA and Circulating Plasma viral RNA pol Genotypes of Subtype C HIV-1.

Banks L, Gholamin S, White E, Zijenah L, Katzenstein DA.

J AIDS Clin Res. 2012 Feb;3(2):141-147.

26.

Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.

Tavana S, Argani H, Gholamin S, Razavi SM, Keshtkar-Jahromi M, Talebian AS, Moghaddam KG, Sepehri Z, Azad TM, Keshtkar-Jahromi M.

Influenza Other Respir Viruses. 2012 Mar;6(2):136-41. doi: 10.1111/j.1750-2659.2011.00290.x. Epub 2011 Sep 28.

27.

Cystic lymphangioma of the pancreas: diagnostic and therapeutic challenges.

Fahimi H, Faridi M, Gholamin S, Molanaee S, Khorsandi M.

JOP. 2010 Nov 9;11(6):617-9. Erratum in: JOP. 2010;11(6):619. Gholamin, Seemin [corrected to Gholamin, Sharareh]; Molanaee, Sharareh [corrected to Molanaee, Simin].

28.

Brucella endocarditis, a report of 14 cases (1991-2009).

Keshtkar-Jahromi M, Boroumand M, Razavi SM, Gholamin S, Haghighat B, Hashemi MJ, Khani M, Keshtkar-Jahromi M, Naghili B.

J Infect. 2010 Jul;61(1):89-92. doi: 10.1016/j.jinf.2010.03.027. Epub 2010 Mar 31. No abstract available.

PMID:
20362000
29.

Antibody response to influenza immunization in coronary artery disease patients: a controlled trial.

Keshtkar-Jahromi M, Vakili H, Rahnavardi M, Gholamin S, Razavi SM, Eskandari A, Sadeghi R, Vatan-Pour H, Keshtkar-Jahromi M, Haghighat B, Ghaffaripour M, Mokhtari-Azad T.

Vaccine. 2009 Dec 10;28(1):110-3. doi: 10.1016/j.vaccine.2009.09.108. Epub 2009 Oct 9.

PMID:
19819210

Supplemental Content

Loading ...
Support Center